In addition, overexpression of DJ‐1 or Nln through AAV gene therapy can also reduce stroke volume to varying degrees, inhibit pro‐inflammatory cytokines, promote the expression of anti‐inflammatory factors, and alleviate stroke injury.53, 54. The gene discussed is NLN; the disease is Stroke.